W.J. Bradshaw
Papers
2
Total Citations
12
H-Index
2
About
W.J. Bradshaw is a leading researcher in fragment-based drug discovery, specializing in innovative methodologies to overcome the critical bottleneck of progressing weak fragment hits into potent lead compounds. Bradshaw’s major contribution is the development of **Binding-Site Purification of Actives (B-SPA)**, a groundbreaking technique that integrates multi-step array synthesis with high-throughput (HT) crystallography. This approach enables the efficient, large-scale exploration of chemical space around fragment hits, directly visualizing binding modes and accelerating the hit-to-lead process. By addressing the long-standing “progression problem” in fragment-based ligand discovery, Bradshaw’s work has the potential to unlock the full transformative power of fragment screening. The seminal 2025 paper on B-SPA has already garnered 9 citations, while the foundational 2024 study has 3, signaling growing recognition in the field. Bradshaw’s research is notable for its practical, scalable solution to a challenge that has historically limited fragment-based approaches, offering a powerful new tool for medicinal chemists and structural biologists. This work positions Bradshaw as a key innovator in streamlining early-stage drug discovery.
Research Focus
Key Achievements
Top Papers
- 1
- 2